Latest Strategy Changes News

OZZ Resources plans to acquire a nickel-copper-cobalt project in Western Australia’s Murchison region, aiming to raise up to $5 million to fund exploration and return to ASX listing.

OD6 Metals is progressing its acquisition option for the Quinn Fluorspar Project in Nevada, a high-grade fluorspar asset poised to address the United States' complete import reliance on this critical mineral vital to semiconductor, battery, and defense sectors.

Stelar Metals (ASX:SLB) is accelerating exploration at its Hill of Leaders Tungsten Project in the Northern Territory, aiming to capitalise on soaring tungsten prices and critical mineral demand driven by Chinese export restrictions.

Sarama Resources has raised A$1.5 million through a private placement to fund copper-gold exploration in New South Wales and support its US$242 million arbitration claim against Burkina Faso. The arbitration hearing is set for February 2027, while Sarama plans to retain significant equity in Riedel Resources following a major asset sale.

Ovanti Limited is proposing to issue over 520 million free-attaching options to recent placement investors and its lead manager, exercisable at $0.025 and expiring in 2030, pending shareholder approval.

Strata Minerals’ Phase 2 drilling at Zelica confirms consistent shallow high-grade gold over a 1km strike, revealing new plunging shoots and a hanging-wall lode that could expand the system across a 9.5km corridor.

RAS Technology Holdings has locked in new contracts and extensions expected to add at least $2 million in annualised revenue, reinforcing growth in wagering technology and international markets.

MyEco Group has extended its partnership with Penrith City Council by winning a 3-to-5-year contract to supply compostable caddy liners for the council's FOGO program, aligning with NSW's mandated organics recycling rollout.

Mach7 Technologies has secured a five-year, A$1.7 million subscription contract with US teleradiology provider AMRADNET, slashing deployment time from 12 months to just 45 days.

Close the Loop Limited has sold its ISP Tek Services business for US$10 million, slashed US$16 million of debt, and set an optimistic EBITDA target of $14 million to $16 million for FY27, signalling a sharper focus on its packaging and resource recovery strengths.

Patrys has appointed CMAX and Alithia Life Sciences to lead its Phase 1A clinical trial operations for RLS-2202, advancing its injectable quetiapine program toward first-in-human testing in Q3 2026, pending ethics approval.

Thrive Tribe Technologies (ASX:1TT) is issuing approximately 116.87 million Loyalty Options to shareholders at no cost, exercisable at $0.003 each and expiring in 2029, aiming to reward loyalty and potentially raise capital upon exercise.